LDA analysis for Study ST000661

(Analysis AN001008 )

Select 3 or more experimental factors for PCA analysis.
GroupExperimental factor
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:1 Month | Treatment:Ornish | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:1 Month | Treatment:Southbeach | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:6 Months | Treatment:Ornish | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:6 Months | Treatment:Southbeach | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:Baseline | Treatment:Ornish | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:Baseline | Treatment:Southbeach | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:0 Days | Treatment:Baseline | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Plasma | Sample_Source:POOLED | Species:Homo sapiens | Study:POOLED | Time_Point:POOLED | Treatment:POOLED | Type:POOLED
Sample type:Plasma | Sample_Source:POOLED | Species:Rattus | Study:POOLED | Time_Point:POOLED | Treatment:POOLED | Type:POOLED
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:0 Days | Treatment:Baseline | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Tissues | Sample_Source:POOLED | Species:Rattus | Study:POOLED | Time_Point:POOLED | Treatment:POOLED | Type:POOLED

OR

Perform LDA on individual factors (all analyses in study)
  logo